DESREM™| Remdesivir for Injection|Official Website
To know about DESREMTM availability in the market, guide your patients to reach Viatris® COVID-19 24/7 helpline @ 7829980066, Email:
For Use By Specialist in Hospital/Institutional Set-Up Only


For treatment of suspected or laboratory confirmed corona virus disease 2019 (COVID-19) in adults and children hospitalized with moderate to severe disease.

Press Release

Mylan gets DCGI nod for remdesivir in India, to Launch at Rs. 4,800 per vial
Mylan launches generic version of Remdesivir in India for Covid-19 patients

Data on File. Remdesivir for Injection 100 mg vial approval letter. Mylan Laboratories Limited. 2020.